Plus Therapeutics highlights CNSide role after NCCN guideline update

Go back to Plus Therapeutics highlights CNSide role after NCCN guideline update
(NASDAQ: PSTV) Delayed: 3.86 +0.08 (2.12%)
Previous Close $3.78    52 Week High
Open $3.81    52 Week Low
Day High $4.00    P/E N/A 
Day Low $3.81    EPS
Volume 56,486